RESUMEN
We previously reported that copper efflux from C6 rat glioma cells was blocked by a brief exposure to sulfhydryl reagents p-chloromercuribenzoate (PCMB) and iodoacetamide as well as dicyclohexylcarbodiimide, suggesting the possible involvement of a Cu-transporting ATPase in the efflux mechanism. In this report, we show that copper efflux from PC12 cells, a neuron-like cell line established from rat adrenal pheochromocytoma, is also inhibited by PCMB exposure. Furthermore, we show that both C6 and PC12 cells express a homolog of the Menkes gene (MNK) as detected by RT-PCR with primers designed from a mouse cDNA and confirmed by sequence analysis of the amplified product. An expected 760-bp fragment representing the transduction and phosphorylation domains and a 925-bp fragment encoding the heavy metal-binding domain of Atp7a were amplified from a RNA extract of C6 and PC12 cells. Sequence data revealed that 690 bp of the 760-bp fragment from C6 cells were an identical match to a similar fragment from PC12 cells. Both fragments encoded a 229 amino-acid polypeptide that had a 98.7% sequence homology to mouse Atp7a. In addition, 880 bp from the 925-bp fragment of the two cell lines were identical and encoded a 293 amino-acid polypeptide with 94.5% sequence homology to mouse Atp7a. These data establish that a Menkes-type Cu-transporting ATPase is expressed in rat C6 and PC12 cells and strongly support the hypothesis that both neurons and glia are involved in maintaining Cu homeostasis in the central nervous system.
Asunto(s)
Adenosina Trifosfatasas/genética , Adenosina Trifosfatasas/metabolismo , Encéfalo/metabolismo , Proteínas Portadoras/genética , Proteínas Portadoras/metabolismo , Proteínas de Transporte de Catión , Cobre/metabolismo , Proteínas Recombinantes de Fusión , Reactivos de Sulfhidrilo/farmacología , Adenosina Trifosfatasas/química , Neoplasias de las Glándulas Suprarrenales , Secuencia de Aminoácidos , Animales , Secuencia de Bases , Proteínas Portadoras/química , Cloromercuribenzoatos/farmacología , ATPasas Transportadoras de Cobre , Cartilla de ADN , ADN Complementario , Diciclohexilcarbodiimida/farmacología , Glioma , Homeostasis , Humanos , Yodoacetamida/farmacología , Síndrome del Pelo Ensortijado/genética , Ratones , Modelos Neurológicos , Datos de Secuencia Molecular , Neuronas/metabolismo , Células PC12 , Feocromocitoma , Reacción en Cadena de la Polimerasa , Ratas , Alineación de Secuencia , Homología de Secuencia de Aminoácido , Homología de Secuencia de Ácido Nucleico , Células Tumorales Cultivadas , Ácido p-CloromercuribenzoicoRESUMEN
Inactivation of mung bean glyceraldehyde-3-phosphate dehydrogenase (GPDH) with excess iodoacetate or N-ethylmaleimide exhibits pseudo-first order kinetics at pH 7.3 and 8.6 in the absence and presence of NAD+, suggesting that all the reactive SH groups (four per tetrameric GPDH molecule) have equivalent reactivity towards these reagents. This is similar to the D2-symmetry conformation proposed on the basis of thermal inactivation data [Malhotra and Srinivasan, Arch. Biochem. Biophys. 236, 775-781 (1985)]. With p-chloromercury benzoate (p-CMB), the inactivation of GPDH is very fast and its kinetics can be monitored at low reagent concentration only. Keeping a high molar p-CMB: enzyme ratio (= 47), the kinetics were found to be biphasic, with half of the activity being lost in a fast and the remaining in a slow phase, characteristic of C2-symmetry conformation and half site reactivity. The p-CMB inactivation could be largely reversed on the addition of excess cysteine. A comparison of these data with literature reports on this and other GPDHs reveals that all reagents having large non-polar moieties exhibit half site reactivity with this enzyme.
Asunto(s)
Gliceraldehído-3-Fosfato Deshidrogenasas/antagonistas & inhibidores , Gliceraldehído-3-Fosfato Deshidrogenasas/química , Conformación Proteica , Reactivos de Sulfhidrilo/farmacología , Animales , Cloromercuribenzoatos/farmacología , Etilmaleimida/farmacología , Fabaceae/enzimología , Cinética , Plantas/enzimología , Plantas Medicinales , Conejos , Ratas , Saccharomyces cerevisiae/enzimología , Porcinos , Ácido p-CloromercuribenzoicoRESUMEN
The transport activity of Band 3 of spectrin-stripped inside-out erythrocyte membrane vesicles (IOVs) or resealed ghosts was enhanced in the presence of trace amounts of Na2SeO3 (0.2-0.5 p.p.m.); however, at higher concentrations of Na2SeO3 (> 4.0 p.p.m.), an inverse result was obtained. Reassociation of spectrin with IOVs has no effect either on the transport activity of Band 3 or on the enhancement of its activity by Na2SeO3. Sulfhydryl reagents (p-chloromercuribenzoic acid and N-ethylmaleimide) could also inhibit Band 3 activity and eliminate the selenium effect. It is suggested that SH groups are involved in anion transport of Band 3 and that the selenium effect is based on the interaction of SH groups of Band 3 with Na2SeO3.
Asunto(s)
Proteína 1 de Intercambio de Anión de Eritrocito/efectos de los fármacos , Membrana Eritrocítica/efectos de los fármacos , Transporte Iónico/efectos de los fármacos , Selenio/farmacología , Cloromercuribenzoatos/farmacología , Membrana Eritrocítica/metabolismo , Humanos , Técnicas In Vitro , Espectrina/fisiología , Ácido p-CloromercuribenzoicoRESUMEN
1. The addition of 9000 g supernatant of rat liver homogenate (S9) or rat liver microsomal fractions to a cytotoxicity test system using BCL-D1 cells has been investigated. 2. The choice of culture medium influenced the intrinsic cytotoxicity of the metabolising system to the BCL-D1 cells. Use of Ham's F10 nutrient mixture resulted in greater cytotoxicity compared with several other media. 3. Microsomal fractions provided greater cytochrome P-450 dependent activation of cyclophosphamide and were less cytotoxic than S9. 4. Direct-acting toxic compounds, such as p-aminophenol, were less toxic in the presence of a metabolising system. This was due to protein-binding rather than enzymic detoxification.
Asunto(s)
Supervivencia Celular/efectos de los fármacos , Hígado/metabolismo , Microsomas Hepáticos/metabolismo , Acroleína/metabolismo , Acroleína/farmacología , Aminofenoles/metabolismo , Aminofenoles/farmacología , Animales , Biotransformación , Línea Celular , Cloromercuribenzoatos/metabolismo , Cloromercuribenzoatos/farmacología , Clorpromazina/metabolismo , Clorpromazina/farmacología , Medios de Cultivo , Ciclofosfamida/metabolismo , Ciclofosfamida/farmacología , Evaluación Preclínica de Medicamentos/métodos , Cinética , Masculino , Ratas , Ratas Endogámicas , Ácido p-CloromercuribenzoicoRESUMEN
A comparative study of selenate and selenite assimilation by Salmonella typhimurium revealed that selenite was not transported by the sulphate permease. Selenite uptake could be detected both in wild-type cells repressed for sulphate transport and in mutants that lacked a functional sulphate permease. In contrast, selenate was assimilated by the same process as was sulphate; selenate transport was repressed under the same conditions which repressed sulphate uptake and was absent in permeaseless mutants. Selenite transport was absent if cells were glucose starved or treated with either azide or p-chloromercuribenzoate. The pH optimum was between pH 6 and pH 7; transport was most rapid at 36 degrees C. The double reciprocal plot for selenite transport at different substrate concentrations was biphasic: between 10 and 50 microM SeO32(-) the apparent Km was 37.8 microM, and at higher concentrations, 2.87 mM. The transport rate for 0.1 mM SeO32(-) was significantly stimulated by sulphite concentrations up to 5.0 mM, with a maximum at 3.0 mM SO32-. The results establish a selenite transport process, in S. typhimurium, as the initial step of an assimilatory pathway selective for selenium.
Asunto(s)
Salmonella typhimurium/metabolismo , Compuestos de Selenio , Selenio/metabolismo , Azidas/farmacología , Transporte Biológico/efectos de los fármacos , Cloranfenicol/farmacología , Cloromercuribenzoatos/farmacología , Concentración de Iones de Hidrógeno , Cinética , Ácido Selénico , Ácido Selenioso , Sulfatos/metabolismo , Sulfitos/farmacologíaRESUMEN
The 490 quinone, a natural sulfhydryl-arylating reagent from the mushroom, Agaricus bisporus, markedly inhibited L1210 murine leukemia DNA polymerase alpha while resulting in little inhibition of DNA polymerase beta from this source. This quinone was more strongly inhibitory than p-chloromercuri-benzoate or N-ethylmaleimide and was less readily neutralized by sulfhydryl-containing molecules such as dithioerythritol. Preliminary experiments indicate that DNA protects DNA polymerase alpha from inhibition by the 490 quinone. The inhibition of DNA synthesis by quinone 490 may contribute significantly to the cytotoxicity of this compound and to the potential of gamma-L-glutaminyl-4-hydroxybenzene as an antitumor agent.
Asunto(s)
ADN Polimerasa II/antagonistas & inhibidores , ADN Polimerasa I/antagonistas & inhibidores , Leucemia L1210/tratamiento farmacológico , Inhibidores de la Síntesis del Ácido Nucleico , Reactivos de Sulfhidrilo/farmacología , Animales , Antineoplásicos , Sitios de Unión , Cloromercuribenzoatos/farmacología , ADN Polimerasa I/metabolismo , ADN Polimerasa II/metabolismo , ADN de Neoplasias/biosíntesis , Ditiotreitol/farmacología , Evaluación Preclínica de Medicamentos , Etilmaleimida/farmacología , Leucemia L1210/enzimología , Leucemia L1210/metabolismo , Ratones , Ratones Endogámicos DBA , Reactivos de Sulfhidrilo/metabolismo , Reactivos de Sulfhidrilo/uso terapéuticoRESUMEN
The authors study in vitro the conversion of 18 hydroxycorticosterone into aldosterone in duck adrenal subcellular fractions. The enzymatic nature of this conversion is studied by classical enzymologic tests. All results are in favor of an enzymatic conversion and this enzyme is strictly located in the mitochondrial fraction. Results concerning this localisation are expressed as specific activity and relative specific activity. Preliminary results on further experimental data point out that this conversion depends on the energetic state of mitochondria. Complete electron transfer blokage inhibits this transformation whereas respiratory chain blokage with a NADPH generating system and ATP supplementation does not seem to produce any inhibition. Oligomycine and guanidine stimulation suggest that ATP or its precursors may be involved in this reaction.
Asunto(s)
18-Hidroxicorticosterona/metabolismo , Glándulas Suprarrenales/metabolismo , Aldosterona/biosíntesis , Corticosterona/análogos & derivados , Glándulas Suprarrenales/efectos de los fármacos , Glándulas Suprarrenales/ultraestructura , Animales , Cloromercuribenzoatos/farmacología , Cobre/farmacología , Patos , Yodoacetamida/farmacología , Cinética , Masculino , Mitocondrias/metabolismo , Fracciones Subcelulares/metabolismo , TemperaturaRESUMEN
When added to Eagle's Minimum Essential Medium supplemented with 10% bovine serum (MEM-10BS), 1mM cysteine was highly toxic to cultured cells. This toxicity was eliminated by (a) preincubation of the medium at 37 degrees C for 24 hr before use, or (b) presence of 5mM pyruvate. Similar results were obtained with freshly prepared CMRL 1066 supplemented with 10% bovine serum (CMRL-10BS), which contains 1.5 mM cysteine as an original ingredient. Medium L 15 supplemented with 10% bovine serum (L-10BS), which contains both 1 mM cysteine and 5 mM pyruvate, supported cell growth. On incubation of MEM-10BS supplemented with 1 mM cysteine (MEM-10BS-1CySH) or CMRL-10BS without cells for one day, the cysteine concentrations decreased to about one-tenth or less of the original concentrations. The cysteine concentration in L-10BS did not decrease so much on similar incubation. Pyruvate reduced the rate of disappearance of the cysteine in MEM-10BS-1CySH or CMRL-10BS as assayed with p-chloromercuribenzoate, although less than that in L-10BS. This effect of pyruvate was concentration dependent. These paradoxical effects of pyruvate on cysteine, i.e. the reduction of its cytotoxicity and the stabilization as an SH compound, are probably due to the formation of a dissociable complex between these two compounds, which is not cytotoxic and resistant to oxidation.
Asunto(s)
Células Cultivadas/efectos de los fármacos , Cisteína/farmacología , Animales , Sangre , Bovinos , División Celular/efectos de los fármacos , Línea Celular , Células Cultivadas/fisiología , Cloromercuribenzoatos/farmacología , Medios de Cultivo , Pruebas Inmunológicas de Citotoxicidad , Ditiotreitol/farmacología , Técnicas In Vitro , Mercaptoetanol/farmacología , Piruvatos/farmacología , TemperaturaAsunto(s)
Dihidrolipoamida Deshidrogenasa/metabolismo , Grano Comestible/microbiología , Cuerpos de Inclusión Viral , Virus del Mosaico/enzimología , Virus de Plantas/enzimología , Secale/microbiología , Microbiología del Suelo , Cloromercuribenzoatos/farmacología , Citoplasma/enzimología , Calor , Virus del Mosaico/crecimiento & desarrollo , Virus del Mosaico/ultraestructura , NAD/metabolismo , NADP/metabolismo , NADPH Deshidrogenasa/metabolismo , Enfermedades de las Plantas , Extractos Vegetales , TriticumRESUMEN
The (Na+ 4 K+)- and Mg2+-dependent ATPase distribution in several brain areas has been investigated in Quaking mutant mice characterized by myelin deficiency. A marked decrease of (Na+ + K+)-ATPase activity has been found in limbic structures, hypothalamus and cerebellum. The Mg2+-dependent activity did not change. A possible involvement of the impairment of the (Na+ + K+)-ATPase activity in the seizure susceptibility of this mice is discussed.
Asunto(s)
Adenosina Trifosfatasas/metabolismo , Encéfalo/enzimología , Epilepsia/enzimología , Animales , Encéfalo/efectos de los fármacos , Cerebelo/enzimología , Corteza Cerebral/enzimología , Cloromercuribenzoatos/farmacología , Fluoruros/farmacología , Hipotálamo/enzimología , Sistema Límbico/enzimología , Magnesio/farmacología , Masculino , Bulbo Raquídeo/enzimología , Ratones , Vaina de Mielina , Proteínas del Tejido Nervioso/deficiencia , Puente/enzimología , Potasio/farmacología , Sodio/farmacologíaRESUMEN
H-Meromyosin (CMB leads to betaME-H-meromyosin) was prepared by tryptic digestion of myosin, which had been treated with CMB bound to H-meromyosin and the extent of desensitization of the substrate inhibition of acto-H-meromyosin ATPase [EC 3.6.1.3.] was investigated. Both the dissociation of acto-H-meromyosin induced by ATP and substrate inhibition decreased with increase in the amount of bound CMB to a minimum value at about 1 mole of CMB bound per mole of H-meromyosin. The substrate inhibition of acto-H-meromyosin ATPase was restored to the original level by complete removal of the bound CMB by further treatment of CMB leads to beta ME-H-meromyosin with a large excess of beta-mercaptoethanol. The dissociation constant of acto-H-meromyosin in the presence of ATP decreased markedly on modification with CMB, while the maximum ATPase activity ar a sufficiently high concentration of F-actin remained essentially unchanged. Acto-H-meromyosin was reconstituted from F-actin and CMB LEADS TO beta ME-H-meromyosin, containing less than the stoichiometric amount of bound CMB. Its ATPase activity and the extent of dissociation of acto-H-meromyosin induced by ATP were explained as those of a mixture of unmodified H-meromyosin and CMB leads to beta ME-H-meromyosin containing 1 mole of CMB per mole of H-meromyosin. Half of the light chains (g2), with a molecular weight of 18,000, were removed from myosin by treatment with CMB and beta-mercaptoethanol. After this treatment, on further incubation of the myosin with a large excess of beta-mercaptoethanol, the myosin contained only half of the g2, but the substrate inhibition of acto-H-meromyosin ATPase was restored completely. The initial burst of P1 liberation and the EDTA-ATPase activity decreased to almost zero on specific modification of the SH1-groups with NEM, while the initial burst decreased to some extent and the EDTA-ATPase activity to 50% of the original value on binding of 1 mole CMB per mole of H-meromyosin. The actomyosin-type of ATPase activity was strongly inhibited by modification with CMB. The extent of the dissociation of acto-H-meromyosin induced by ATP was unaffected by modification with NEM, while it decreased on further treatment of NEM-myosin with CMB FOLLOWED BY BETA-MERCAPTOETHANOL.